Jay & Raman Bhaumik Announce Thesis Pharmacy Rebranding from Texas Star, Signaling Precision Growth and National Expansion
Thesis Pharmacy today announced its official rebrand from Texas Star Pharmacy, marking a major milestone in its growth as a leading national compounding provider licensed in over 40 states. Co-owners Raman and Jay Bhaumik selected the name Thesis Pharmacy to reflect its foundation in research, precision, and purpose-driven care.
Jay Bhaumik’s Visionary Leadership Propels Thesis Pharmacy to 2025 Inc. 5000 List
Thesis Pharmacy has earned the rank of No. 988 on the 2025 Inc. 5000 list, recognizing the company as one of the fastest-growing private businesses in the United States. Achieving a remarkable 433% three-year growth, Thesis Pharmacy continues to advance its mission of providing personalized pharmacy services through innovation, specialized compounding, and complementary home delivery.
Raman Bhaumik to Represent Thesis Pharmacy at A4M Longevity Fest 2025
Raman Bhaumik, an entrepreneur and licensed pharmacist, will represent Thesis Pharmacy at A4M’s Longevity Fest 2025, held December 12–14, 2025, at The Venetian and Palazzo Resort in Las Vegas. The event, hosted by the American Academy of Anti-Aging Medicine (A4M), is widely recognized as one of the most influential gatherings for longevity and wellness professionals worldwide.
